Home » Topics » BioWorld Science

BioWorld Science
RSS

Clec9A-M2e construct may be a step towards a universal influenza vaccine

May 10, 2022

Discovery of potent and orally bioavailable CSNK1A1 inhibitors

May 10, 2022

Shanghai De Novo Pharmatech synthesizes new ATR kinase inhibitors

May 10, 2022

Beijing Jacobio Pharmaceuticals identifies new glutaminase inhibitors

May 10, 2022

Ranok Therapeutics presents new CHAMPs for cancer

May 10, 2022

Universite du Luxembourg discloses new PDE6D inhibitors

May 10, 2022

Hangzhou Zhongmei Huadong Pharmaceutical divulges GLP-1 receptor agonists

May 10, 2022

Targeting NMNAT2 confers neuroprotection in glaucoma

May 10, 2022

AGEN-1571 reverses ILT-2-mediated immunosuppression to activate antitumor immunity

May 9, 2022

Studies identify genetic risk factors for hyperemesis gravidarum and recurrence

May 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...